SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
______________________________________________________________________________
June 28, 2000
Date of Report (Date of earliest event reported)
AQUILA BIOPHARMACEUTICALS, INC.
(Exact name of registrant as specified in charter)
Delaware 0-12081 04-3307818
(State or other (Commission File Number) (IRS Employer Identification #)
jurisdiction of
incorporation)
175 Crossing Boulevard
Framingham, Massachusetts 01702
(Address of principal executive offices and zip code)
(508) 628-0100
(Registrant's telephone number, including area code)
_____________________________________________________________________________
Item 5. Other Events.
James L. Warren has resigned as Treasurer/CFO of the Company. Melissa
Packard was elected Treasurer on June 28, 2000. Mr. Warren's last day with
the Company was July 7, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AQUILA BIOPHARMACEUTICALS, INC.
Date: July 13, 2000 By: /s/ Alison Taunton-Rigby
Alison Taunton-Rigby, Chief Executive Officer
{J:\clients\bus\011301\0192\00155672.DOC;1}
